This site is intended for health professionals only

Editor’s pick

EMA undertakes penultimate Multaq review
EMA undertakes penultimate Multaq review
IEC: ‘Zebinix® can replace standard monotherapy’
IEC: ‘Zebinix® can replace standard monotherapy’
IEC: ‘Perampanel significantly reduces seizure frequency’
IEC: ‘Perampanel significantly reduces seizure frequency’
IEC: Zonisamide proves comparable to carbamazepine
IEC: Zonisamide proves comparable to carbamazepine
IEC: ‘Zonegran effective and well-tolerated in children’
IEC: ‘Zonegran effective and well-tolerated in children’
ESC: Prasugrel receives Class 1 PCI recommendation
ESC: Prasugrel receives Class 1 PCI recommendation
EMA review lung cancer drug approved by FDA
EMA review lung cancer drug approved by FDA
Novartis camp highlights importance of diversity
Novartis camp highlights importance of diversity
FDA requests information on arthritis drug
FDA requests information on arthritis drug
ESC: Dalcetrapib well tolerated in CVD patients
ESC: Dalcetrapib well tolerated in CVD patients
ESC: CVD therapy underuse linked to income
ESC: CVD therapy underuse linked to income
ESC: Darexaban associated with DAPT bleeding increase
ESC: Darexaban associated with DAPT bleeding increase
1 … 4 5 6 7 8 … 302





Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2026
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x